FI94094C - Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle - Google Patents

Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle Download PDF

Info

Publication number
FI94094C
FI94094C FI881409A FI881409A FI94094C FI 94094 C FI94094 C FI 94094C FI 881409 A FI881409 A FI 881409A FI 881409 A FI881409 A FI 881409A FI 94094 C FI94094 C FI 94094C
Authority
FI
Finland
Prior art keywords
release
powder
tablets
granules
cystine
Prior art date
Application number
FI881409A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI881409L (fi
FI94094B (fi
FI881409A0 (fi
Inventor
Yoshimitsu Iida
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI881409A0 publication Critical patent/FI881409A0/fi
Publication of FI881409L publication Critical patent/FI881409L/fi
Publication of FI94094B publication Critical patent/FI94094B/fi
Application granted granted Critical
Publication of FI94094C publication Critical patent/FI94094C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI881409A 1987-03-24 1988-03-24 Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle FI94094C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6967787 1987-03-24
JP6967787 1987-03-24

Publications (4)

Publication Number Publication Date
FI881409A0 FI881409A0 (fi) 1988-03-24
FI881409L FI881409L (fi) 1988-09-25
FI94094B FI94094B (fi) 1995-04-13
FI94094C true FI94094C (fi) 1995-07-25

Family

ID=13409722

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881409A FI94094C (fi) 1987-03-24 1988-03-24 Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle

Country Status (13)

Country Link
US (1) US5057317A (forum.php)
EP (1) EP0284039B1 (forum.php)
KR (1) KR960005141B1 (forum.php)
AT (1) ATE78157T1 (forum.php)
AU (1) AU603878B2 (forum.php)
CA (1) CA1324081C (forum.php)
DE (1) DE3872739T2 (forum.php)
DK (1) DK174992B1 (forum.php)
ES (1) ES2051782T3 (forum.php)
FI (1) FI94094C (forum.php)
GR (1) GR3005818T3 (forum.php)
IE (1) IE62487B1 (forum.php)
NO (1) NO175405C (forum.php)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68907066T2 (de) * 1988-01-29 1993-12-16 Koken Kk Verbesserte Formulierungen mit kontrollierter Abgabe.
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
IT1256022B (it) * 1992-06-08 1995-11-20 Preparazioni farmaceutiche stabili di nicorandil
DK0644771T4 (da) † 1992-06-11 2006-12-27 Alkermes Inc Lægemiddelsystem til levering af erythropoietin
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
GB9505032D0 (en) 1995-03-13 1995-05-03 Westminster Lab Ltd Improvements in or relating to organic compositions
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
US6416778B1 (en) 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
EP1077065B1 (en) * 1998-05-15 2004-08-04 Chugai Seiyaku Kabushiki Kaisha Controlled release formulations
EP1133230A4 (en) 1998-11-23 2004-05-26 Bonnie M Davis DOSAGE FORMULAS FOR ACETYLCHOLINESTERASE INHIBITORS
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US7018654B2 (en) * 1999-03-05 2006-03-28 New River Pharmaceuticals Inc. Pharmaceutical composition containing an active agent in an amino acid copolymer structure
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
DE60025201T2 (de) * 1999-06-09 2006-06-29 Mochida Pharmaceutical Co. Ltd. System für wirkstofffreisetzung im unteren verdauungstrakt
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
EP1455697A4 (en) * 2001-12-20 2009-08-05 Femmepharma Holding Co Inc VAGINAL DRUG DELIVERY
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
WO2004060322A2 (en) * 2003-01-02 2004-07-22 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
CA2674078C (en) * 2006-12-26 2012-03-20 Femmepharma Holding Company, Inc. Topical administration of danazol
JP5366558B2 (ja) * 2006-12-28 2013-12-11 武田薬品工業株式会社 口腔内崩壊性固形製剤
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
AU2020257406A1 (en) * 2019-04-19 2021-12-16 Hoffman Technologies Llc Sustained release formulations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2753288A (en) * 1953-01-12 1956-07-03 Upjohn Co Scopolamine lower-alkyl halide therapeutic composition
US3477864A (en) * 1965-05-07 1969-11-11 Sumitomo Chemical Co Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film
GB1155036A (en) * 1966-07-08 1969-06-11 Ethan Allan Brown Injectionable Substance
US3541201A (en) * 1968-12-18 1970-11-17 Ethan Alan Brown Novel sodium chloride encapsulated injectionable substances
US3786123A (en) * 1971-01-25 1974-01-15 S Katzen Method for stabilizing and preserving nutrients and products
GB1377074A (en) * 1971-07-13 1974-12-11 Beecham Group Ltd Process for preparing injectable compositions
GB1492973A (en) * 1974-02-16 1977-11-23 Beecham Group Ltd Process for preparing injectable compositions
US4070455A (en) * 1974-02-16 1978-01-24 Beecham Group Limited Process for preparing injectable desensitizing compositions and products thereof in microparticle form
LU69456A1 (forum.php) * 1974-02-22 1975-12-09
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JPS5835110A (ja) * 1981-08-28 1983-03-01 Tetsuo Kato 徐放性マイクロカプセル
US4457907A (en) * 1982-08-05 1984-07-03 Clear Lake Development Group Composition and method for protecting a therapeutic drug
IT1177384B (it) * 1984-12-12 1987-08-26 Boeehringer Biochemia Robin Sp Prodotti dietetici granulari a base di amminoacidi e procedimento per la loro preparazione
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy

Also Published As

Publication number Publication date
ES2051782T3 (es) 1994-07-01
IE880855L (en) 1988-09-24
ATE78157T1 (de) 1992-08-15
DE3872739D1 (de) 1992-08-20
NO175405B (no) 1994-07-04
NO881296D0 (no) 1988-03-24
AU1351788A (en) 1988-09-29
KR960005141B1 (ko) 1996-04-22
US5057317A (en) 1991-10-15
FI881409L (fi) 1988-09-25
FI94094B (fi) 1995-04-13
NO881296L (no) 1988-09-26
NO175405C (no) 1994-10-12
DK174992B1 (da) 2004-04-13
DE3872739T2 (de) 1993-01-21
EP0284039B1 (en) 1992-07-15
EP0284039A3 (en) 1989-01-25
AU603878B2 (en) 1990-11-29
GR3005818T3 (forum.php) 1993-06-07
EP0284039A2 (en) 1988-09-28
KR880010758A (ko) 1988-10-24
FI881409A0 (fi) 1988-03-24
DK158788A (da) 1988-09-25
DK158788D0 (da) 1988-03-23
IE62487B1 (en) 1995-02-08
CA1324081C (en) 1993-11-09

Similar Documents

Publication Publication Date Title
FI94094C (fi) Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle
EP0386801B1 (en) Slow-release pharmaceutical composition
EP0523847B1 (en) Taste mask coating for preparation of chewable pharmaceutical tablets
KR100415897B1 (ko) 생체 이용율이 높은 페노피브레이트 제약학적 조성물
AU623560B2 (en) Pharmaceutical granules and drug dosage units made therefrom
CN101987081B (zh) 一种控释制剂
CN109674752A (zh) 葡萄糖激酶激活剂的口服制剂及其制备方法
HU219462B (hu) Asztemizolt és pszeudoefedrint tartalmazó, nyújtott hatású, filmbevonatos tabletták
JPH0122245B2 (forum.php)
EP0761212A2 (en) Effervescent composition and its production
CA2746884A1 (en) A method of treating insomnia
GB2204241A (en) Fat coated pharmaceutical compositions
CN105832687A (zh) 包含氢吗啡酮和纳洛酮的药物组合物
EP0425298B1 (en) Sustained-release preparation of basic medical agent hydrochloride
EP3024443A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
JP3929522B2 (ja) 難水溶性薬物の徐放性製剤
JP2638604B2 (ja) 徐放性製剤
JPH0130A (ja) 徐放性製剤
EP4076453B1 (en) A pharmaceutical oral dosage form of q203
CN102475719A (zh) 一种用于治疗儿童上呼吸道感染的药物组合物及其制备方法
ES2430333T3 (es) Composiciones de matriz para liberación controlada de principios activos
KR20080071286A (ko) 암로디핀 함유 입자 및 그것을 포함하는 구강 내 붕괴정
JP2003146882A (ja) 生理活性物質含有固形物の溶出速度を制御する方法

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: CHUGAI SEIYAKU KABUSHIKI KAISHA

MA Patent expired